Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06382688
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-24
First Post:
2024-04-04
Brief Title:
IV Administration of ChromaDexs Niagen as Compared to NAD
Sponsor:
Franklin Health Research
Organization:
Franklin Health Research
Study Overview
Official Title:
The Effects of IV Administration of ChromaDexs Niagen Nicotinamide Riboside Chloride as Compared to IV Administration of NAD A Randomized Placebo Controlled Clinical Trial
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 2-part study evaluating the effects of IV administration of NR on healthy adult populations Study 1 involved all four arms with 37 people The second study only included the active NR and NAD arms to further evaluate tolerability and comfort of the IV
Detailed Description:
The purpose of this work is to establish and quantify the safety and efficacy of IV administration of ChromaDexs Niagen nicotinamide riboside chloride in comparison to currently available IV NAD a saline IV and orally administered Niagen
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None